4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-005173
Options or other derivatives
- Chief Executive Officer acquired 500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BELANOFF JOSEPH K Chief Executive Officer | 2023-02-13 | Grant or award · Stock option (right to buy) | +500,000 | 500,000 | D | ||
Loading xslF345X03/doc4.xml…